Recent News

• 06.02.2026 - iBio to Participate in Upcoming Healthcare Investor Conferences
• 06.02.2026 - iBio to Participate in Upcoming Healthcare Investor Conferences
• 06.02.2026 - iBio Becomes a Clinical-Stage Company with First Participant Dosed in Phase 1 Clinical Trial of IBIO-600 in Adults with Obesity
• 05.12.2026 - iBio Reports Q3 Fiscal Year 2026 Financial Results and Provides Corporate Update
• 05.12.2026 - iBio Reports Q3 Fiscal Year 2026 Financial Results and Provides Corporate Update
• 05.08.2026 - iBio Appoints Distinguished Biotech Leader, Elizabeth Stoner, to its Board of Directors
• 05.08.2026 - iBio Appoints Distinguished Biotech Leader, Elizabeth Stoner, to its Board of Directors

Recent Filings

• 05.19.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.15.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 05.15.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 05.15.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 05.15.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 05.15.2026 - 3 Initial statement of beneficial ownership of securities
• 05.15.2026 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 05.14.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 05.12.2026 - EX-99.1 EX-99.1
• 05.12.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]